Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock

被引:56
作者
Fioretto, Jose R. [1 ,2 ]
Martin, Joelma G. [2 ]
Kurokawa, Cilmery S. [2 ]
Carpi, Mario F. [2 ]
Bonatto, Rossano C. [2 ]
de Moraes, Marcos A. [2 ]
Ricchetti, Sandra M. Q. [2 ]
机构
[1] Univ Estadual Paulista, Fac Med Botucatu, Dept Pediat, BR-18618970 Sao Paulo, Brazil
[2] Sao Paulo State Univ, Dept Pediat, Botucatu Med Sch, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Procalcitonin; C-reactive protein; Septic shock; Children; Critical care; BACTERIAL-INFECTION; SERUM PROCALCITONIN; MARKERS; MORTALITY; INTERLEUKIN-6; INDICATOR; FAILURE;
D O I
10.1007/s00011-010-0161-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The objective of the paper is to examine the behavior of C-reactive protein (CRP) and procalcitonin (PCT) in the first 12 h of admission and verify which performs better to differentiate children with septic conditions. Septic children aged between 28 days and 14 years were divided into sepsis (SG; n = 46) and septic shock (SSG; n = 41) groups. CRP and PCT were measured at admission (T0) and 12 h later (T12 h). PCT results were classed as: 0.5 ng/ml = sepsis unlikely; a parts per thousand yen0.5 to < 2 = sepsis possible; a parts per thousand yen2 to < 10 = systemic inflammation; a parts per thousand yen10 = septic shock. At T0, there was a higher frequency of SSG with PCT > 10 compared to SG [SSG: 30 (73.1%) > SG: 14 (30.4%); P < 0.05]. Similar results were observed at T12 h. Pediatric Risk of Mortality I score was significantly higher for SSG patients with higher PCT than SG patients. CRP levels were not statistically different for groups and time points. PCT was better than CRP for diagnosing sepsis and septic shock, mainly at admission, and is related to disease severity.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 37 条
  • [1] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [2] Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
    Balci, C
    Sungurtekin, H
    Gürses, E
    Sungurtekin, U
    Kaptanoglu, B
    [J]. CRITICAL CARE, 2003, 7 (01): : 85 - 90
  • [3] Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
    Becker, Kenneth L.
    Snider, Richard
    Nylen, Eric S.
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (03) : 941 - 952
  • [4] Procalcitonin: A marker of bacteraemia in SIRS
    Bell, K
    Wattie, M
    Byth, K
    Silvestrini, R
    Clark, P
    Stachowski, E
    Benson, EM
    [J]. ANAESTHESIA AND INTENSIVE CARE, 2003, 31 (06) : 629 - 636
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock
    Carcillo, JA
    Fields, AI
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (06) : 1365 - 1378
  • [7] Procalcitonin as a marker of sepsis
    Carrol, ED
    Thomson, APJ
    Hart, CA
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (01) : 1 - 9
  • [8] Casado-Flores Juan, 2003, Pediatr Crit Care Med, V4, P190, DOI 10.1097/01.PCC.0000059420.15811.2D
  • [9] Castelli GP, 2006, MINERVA ANESTESIOL, V72, P69
  • [10] Dellinger RP, 2008, INTENS CARE MED, V34, P783, DOI [10.1007/s00134-007-0934-2, 10.1007/s00134-008-1040-9, 10.1097/01.CCM.0000298158.12101.41]